Your browser doesn't support javascript.
loading
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response.
Loibl, S; Schneeweiss, A; Huober, J; Braun, M; Rey, J; Blohmer, J-U; Furlanetto, J; Zahm, D-M; Hanusch, C; Thomalla, J; Jackisch, C; Staib, P; Link, T; Rhiem, K; Solbach, C; Fasching, P A; Nekljudova, V; Denkert, C; Untch, M.
Affiliation
  • Loibl S; German Breast Group, Neu-Isenburg, Germany; Center for Hematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: sibylle.loibl@gbg.de.
  • Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Huober J; Universitätsklinikum Ulm, Ulm, Germany; Breast Center, Cantonal Hospital, St Gallen, Switzerland.
  • Braun M; Department of Gynecology, Breast Center, Red Cross Hospital, Munich, Germany.
  • Rey J; German Breast Group, Neu-Isenburg, Germany.
  • Blohmer JU; Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Furlanetto J; German Breast Group, Neu-Isenburg, Germany.
  • Zahm DM; SRH Waldklinikum Gera GmbH, Gera, Germany.
  • Hanusch C; Department of Gynecology, Breast Center, Red Cross Hospital, Munich, Germany.
  • Thomalla J; Praxis für Hämatologie und Onkologie Koblenz, Koblenz, Germany.
  • Jackisch C; Sana Klinikum Offenbach, Offenbach, Germany.
  • Staib P; Klinik für Hämatologie und Onkologie, St.-Antonius Hospital, Eschweiler, Germany.
  • Link T; Department of Gynecology and Obstetrics, Technische Universität Dresden, Dresden, Germany.
  • Rhiem K; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Solbach C; Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Frankfurt, Frankfurt, Germany.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-Nuremberg, National Center for Tumour Diseases, Erlangen, Germany.
  • Nekljudova V; German Breast Group, Neu-Isenburg, Germany.
  • Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg (UKGM), Marburg, Germany.
  • Untch M; HELIOS Klinikum Berlin Buch, Berlin, Germany.
Ann Oncol ; 33(11): 1149-1158, 2022 11.
Article in En | MEDLINE | ID: mdl-35961599
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article